(Q42162982)
Statements
Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men (English)
A R van Troostenburg
E V Clark
W D H Carey
S J Warrington
W D Kerns
I Cohn
M H Silverman
S Bar-Yehuda
K L L Fong
1 October 2004